Biomedicines (Sep 2022)

Investigating the Role of Circulating miRNAs as Biomarkers in Colorectal Cancer: An Epidemiological Systematic Review

  • Lucia Dansero,
  • Fulvio Ricceri,
  • Laura De Marco,
  • Valentina Fiano,
  • Ginevra Nesi,
  • Lisa Padroni,
  • Lorenzo Milani,
  • Saverio Caini,
  • Giovanna Masala,
  • Claudia Agnoli,
  • Carlotta Sacerdote

DOI
https://doi.org/10.3390/biomedicines10092224
Journal volume & issue
Vol. 10, no. 9
p. 2224

Abstract

Read online

Colorectal cancer (CRC) is one of the most common cancers worldwide. Primary and secondary preventions are key to reducing the global burden. MicroRNAs (miRNAs) are a group of small non-coding RNA molecules, which seem to have a role either as tumor suppressor genes or oncogenes and to be related to cancer risk factors, such as obesity and inflammation. We conducted a systematic review and meta-analysis to identify circulating miRNAs related to CRC diagnosis that could be selected as biomarkers in a meet-in-the-middle analysis. Forty-four studies were included in the systematic review and nine studies in the meta-analysis. The pooled sensitivity and specificity of miR-21 for CRC diagnosis were 77% (95% CI: 69–84) and 82% (95% CI: 70–90), respectively, with an AUC of 0.86 (95% CI: 0.82–0.88). Several miRNAs were found to be dysregulated, distinguishing patients with CRC from healthy controls. However, little consistency was present across the included studies, making it challenging to identify specific miRNAs, which were consistently validated. Understanding the mechanisms by which miRNAs become biologically embedded in cancer initiation and promotion may help better understand cancer pathways to develop more effective prevention strategies and therapy approaches.

Keywords